Analyst Ratings February 11, 2026

TD Cowen Lifts Coca-Cola Price Target to $85 After Q4 Beat, Cites Achievable Guidance

Analyst keeps Buy rating as company posts margin strength but issues 2026 organic sales guidance that may undershoot expectations

By Avery Klein KO
TD Cowen Lifts Coca-Cola Price Target to $85 After Q4 Beat, Cites Achievable Guidance
KO

TD Cowen raised its price target on Coca-Cola to $85 from $80 and maintained a Buy rating following the company's fourth-quarter results. The firm pointed to strong margins and trailing diluted earnings per share but noted 2026 organic sales guidance of 4-5% may have disappointed investors. Multiple other brokerages also adjusted targets and ratings in the wake of the report.

Key Points

  • TD Cowen raises Coca-Cola price target to $85 from $80 and keeps a Buy rating - impacts consumer staples and equity markets.
  • Company reported strong gross profit margins of 61.63% and trailing diluted EPS of $3.04, with Q4 adjusted EPS of $0.58 beating consensus $0.56-$0.57 - relevant to investors tracking earnings and fundamentals.
  • 2026 organic sales guidance of 4-5% may be below investor expectations despite a 5-year revenue CAGR of 8% and 55 consecutive years of dividend increases - affects outlook for consumer staples demand and dividend-focused strategies.

TD Cowen on Wednesday increased its price target for Coca-Cola (NYSE:KO) to $85.00 from $80.00, while keeping a Buy rating on the beverage company’s stock. At the time of the firm’s revision, Coca-Cola was trading around $77.16 and near its 52-week high of $79.20.

The upgrade follows the company’s fourth-quarter results, which TD Cowen analyst Robert Moskow said included beats to consensus on organic sales and earnings per share. Coca-Cola reported a gross profit margin of 61.63% and a diluted earnings per share figure of $3.04 for the last twelve months, metrics TD Cowen cited in support of the higher target.

Despite the quarterly beat, Coca-Cola issued 2026 organic sales guidance calling for 4-5% growth, a range that TD Cowen suggested may sit below some investor expectations. The guidance was set against the company’s recent performance profile, which includes a reported 5-year revenue compound annual growth rate (CAGR) of 8% and a long-running streak of dividend increases stretching 55 consecutive years.

TD Cowen expressed confidence that Coca-Cola has the ability to reach the high end of the 4-5% organic sales range by relying on a mix of volume gains and price/mix improvement. The firm also highlighted the company’s broad international presence and its local franchisee bottling system as competitive advantages versus peers in the consumer packaged goods space.

Other brokerages adjusted their views after the earnings release. RBC Capital raised its price target to $87 from $78, characterizing the results as solid while flagging some temporary mix headwinds and timing considerations. Barclays lifted its target to $83 and emphasized Coca-Cola’s strategy of balancing pricing and volume. Morgan Stanley stuck with an Overweight rating and a price target of $81 following the report.

The company reported fourth-quarter adjusted earnings per share of $0.58, modestly ahead of consensus estimates that ranged from $0.56 to $0.57. The outperformance was attributed to lower-than-expected interest expenses and taxes rather than to clear operational strength, according to the reporting in the earnings release and subsequent analyst commentary.

In addition to the financial results and target revisions, Coca-Cola announced it will retain full ownership of Costa Coffee and said it is conducting a review of its operations in China, despite earlier considerations of divestment. RBC Capital had reiterated an Outperform rating and a $78 price target ahead of the earnings announcement, indicating expectations that the company would meet consensus estimates.

Collectively, the post-earnings reactions from TD Cowen and other firms reflect a market focus on Coca-Cola’s strategic choices, margin profile, and the durability of near-term sales growth as the company navigates mix dynamics and regional operational reviews.

Risks

  • The 2026 organic sales guidance of 4-5% could disappoint investors accustomed to higher historical growth, creating downside pressure on consumer staples equities.
  • Q4 adjusted EPS outperformance was linked to lower interest and tax expenses rather than operational improvement, which introduces uncertainty about the sustainability of earnings gains - relevant to equity and fixed-income analysis.
  • Temporary mix headwinds, timing factors and the ongoing review of China operations present operational uncertainties that may affect near-term revenue and margin trends in international markets.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026